IP Library Granted Patent US 10,248,757
Granted Patent B2
US 10,248,757 · App. 14/103,259 · Granted Apr 2, 2019

Genetic, metabolic and biochemical pathway analysis system and methods

Inventors: Sorin Draghici (Detroit, MI); Zhonghui Xu (Detroit, MI); Michele Donato (Detroit, MI)
Assignee: WAYNE STATE UNIVERSITY
G06F19/12G06F17/50G06F19/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,248,757
App. No.
14/103,259
Granted
Apr 2, 2019
Kind
B2
Abstract

Identifying pathways that are significantly impacted in a given condition is a crucial step in the understanding of the underlying biological phenomena. All approaches currently available for this purpose calculate a p-value that aims to quantify the significance of the involvement of each pathway in the given phenotype. These p-values were previously thought to be independent. Here, we show that this is not the case, and that pathways can affect each other's p-values through a “crosstalk” phenomenon that affects all major categories of existing methods. We describe a novel technique able to detect, quantify, and correct crosstalk effects, as well as identify novel independent functional modules. We assessed this technique on data from four real experiments coming from three phenotypes involving two species.

Claims (8)

1. A computer-implemented method of correcting for crosstalk effects in analyzing a set of reference pathways and a list of genes or proteins or metabolites or reactants that are differentially expressed in a given condition, comprising:

constructing, via a computer, a matrix whereby each pathway to which any given gene or protein or metabolite or reactant contributes most is identified;

processing, via said computer, the matrix by applying a likelihood-based estimation upon an impact matrix and thereby identify a new set of new and/or existing pathways that is not affected by crosstalk effects;

generating, via said computer, a heat map using the matrix, the heat map illustrating a p-value of each pathway when an influence of genes or proteins or metabolites or reactants from each other pathway are removed;

displaying, via said computer, the heat map; and

treating a patient based on the heat map.

2. The method of claim 1 wherein the likelihood-based estimation includes performing expectation maximization.

3. The method of claim 1 further comprising performing module detection by identifying sub-pathways that have an apparent role in to the given condition, but independent of the pathway to which they belong.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 27, 2017
From: WAYNE STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042352/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2014
From: DRAGHICI, SORIN; XU, ZHONGHUI; DONATO, MICHELE
To: WAYNE STATE UNIVERSITY
Reel/Frame 032958/0553 →
Continuity (2)
Provisional Application 61735732 · Dec 11, 2012
Related Publication 20140172385A1 · Jun 19, 2014